This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tenet Healthcare May Benefit From Obamacare

Peer Competition:

The market is the final say, and although Tenet was up 28% in the past year, United Healthcare Group (UNH - Get Report) was up only 8%, WellPoint (WLP) was down 16% and Cigna (CI - Get Report) was up 21%:

United Healthcare has a financial strength rating of A+ and is rated by TheStreet as an A- stock. Revenue is projected to be up 8.7% next year, and earnings are expected to increase annually by 10.48% for the next five years.

WellPoint has a financial strength of A and is rated as a B by TheStreet. Revenue is expected to increase by 8.2% next year, and earnings should increase by 8.29% annually for the next five years.

Cigna has a financial strength of B++ and TheStreet gives the stock and A rating. Revenue might be up 10.2% next year, and earnings are estimated to increase by 10.21% annually for five years.

Conclusion: With risk comes return, and I look for Tenet to benefit from Obamacare. Analysts expect the earnings to compound by 11.73% annually for the next five years and also expect the annual total return to investors to be in the 25%-30% range for that same period. The stock has gotten good support since July, and the lower 14-day turtle channel shows nice steady increases in that support as is evidenced in the chart below. If you want an Obamacare play, I think you'll find it here.

At the time of publication, VanMeerten held no positions in Tenet Healthcare, but the stock was on his new-purchase watch list.
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
WLP $136.01 1.43%
UNH $132.03 0.00%
CI $135.30 0.00%
THC $31.46 0.00%
AAPL $94.19 0.00%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs